Name Development Level Target Family
Synaptic vesicular amine transporter Tclin Transporter
Name Description
valbenazine The mechanism of action of valbenazine in the treatment of tardive dyskinesia is unknown, but is thought to be mediated through the reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
valbenazine